The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective validation from a retrospective trial that validated an AI/ML-derived whole-genome biomarker as the most accurate and precise predictor of survival and response to treatment in glioblastoma.
 
Orly Alter
Employment - Prism AI Therapeutics, Inc.; https://prism-ai.com
Leadership - Prism AI Therapeutics, Inc.; https://prism-ai.com
Stock and Other Ownership Interests - Prism AI Therapeutics, Inc.; https://prism-ai.com
Patents, Royalties, Other Intellectual Property - 1. O. Alter, “Genetic Alterations in Glioblastoma,” European Patent EP 2773777 A4 (May 2020); https://patents.google.com/patent/EP2773777A4; 2. O. Alter, “Genetic Alterations in Glioma,” United States Patent US 10202643 B2 (February 2019); https://patents.google.com/patent/US10202643B2
 
Sri Priya Ponnapalli
No Relationships to Disclose
 
Jessica W. Tsai
No Relationships to Disclose
 
Penelope Miron
No Relationships to Disclose
 
Kristy L. S. Miskimen
No Relationships to Disclose
 
Kristin A. Waite
No Relationships to Disclose
 
Nadiya Sosonkina
No Relationships to Disclose
 
Sara E. Coppens
No Relationships to Disclose
 
Anthony C. Bryan
No Relationships to Disclose
 
Estevan P. Kiernan
Employment - Illumina
Stock and Other Ownership Interests - Illumina
Travel, Accommodations, Expenses - Illumina
 
Huanming Yang
No Relationships to Disclose
 
Jay Bowen
No Relationships to Disclose
 
Ghunwa Nakouzi
No Relationships to Disclose
 
Jill Barnholtz-Sloan
Employment - Piedmont Health (I)
Leadership - Piedmont Health (I)
Stock and Other Ownership Interests - Surgical Management Professionals (I)
Consulting or Advisory Role - Medtronic (I); Monteris Medical (I)
Research Funding - Lentigen (I); Merck (I)
Other Relationship - National Institute of Health (NIH)
 
Andrew E. Sloan
No Relationships to Disclose
 
Tiffany R. Hodges
No Relationships to Disclose